A study found that a blood test detecting ctDNA after surgery more accurately predicts recurrence and survival in patients with stage 3 colon cancer.

New blood test could improve survival rates of deadly cancer - Pancreatic cancer is the fifth most common cause of cancer ...

Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced the launch of a novel ...

Millions of people donate blood each year, saving countless lives. After a donation, plasma and white blood cells are ...

Ketone test strips The ketogenic diet is a strict, low-carb diet that is gaining in popularity due to claimed health benefits, which include dramatic weight loss, lowered blood triglycerides, ...

Researchers at the Johns Hopkins Kimmel Cancer Center have developed a novel liquid biopsy approach to identify early-stage ...

A new finger prick test claims to detect Alzheimer’s with 91% accuracy using p-tau217 biomarkers. Learn how this accessible ...

Scientists in Sweden and Norway have uncovered a promising way to spot Parkinson’s disease years—possibly decades—before its most damaging symptoms appear. By detecting subtle biological signals in ...

A study into the long-term health impacts of coronavirus, led by experts from the University of Leicester, Imperial College ...

The World Anti-Doping Agency (WADA) is pleased to publish the revised International Standard for Testing and ...

A potential blood test can distinguish ME/chronic fatigue syndrome with great accuracy, after years of medical uncertainty.

Health authorities earlier named 2 Hong Kong-based companies linked to alleged smuggling of blood samples for gender testing ...